病例报告:移植后淋巴增殖障碍是血管化复合性全移植的严重并发症
Alessandra Zaccardelli1, Fabienne M Lucas2, Ann S LaCasce3
1Department of Medical Education, Tufts University School of Medicine, Boston, MA, United States.
Frontiers in transplantation
|July 12, 2024
概括
移植后淋巴增殖性疾病 (PTLD) 可能发生在血管化复合性全移植 (VCA) 后. 本综述侧重于VCA患者的PTLD流行病学,表现和治疗.
科学领域:
- 移植手术 移植手术
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 血管化复合性全体移植 (VCA) 是一项复杂的手术程序,存在相关风险.
- 免疫抑制在VCA后是必要的,但会增加并发症的风险.
- 移植后淋巴增殖障碍 (PTLD) 是各种移植后已知的并发症.
更多相关视频
10:31Surgical Angiogenesis in Porcine Tibial Allotransplantation: A New Large Animal Bone Vascularized Composite Allotransplantation Model
Published on: August 13, 2017
7.6K
09:09A Modified Heterotopic Swine Hind Limb Transplant Model for Translational Vascularized Composite Allotransplantation VCA Research
Published on: October 14, 2013
12.5K
